Citigroup’s Catheter Precision VTAK Stock Holding History
Bought
Maintained
Sold
Other funds holding VTAK
VF
TRCT
AF
PUI
HI
SS
Citigroup's VTAK Position: Q2 2026 in Review
Citigroup increased its Catheter Precision (VTAK) stake by 2,100% in Q2 2026, buying an estimated $20 and bringing the position to 22 shares worth $19. The position accounts for ﹤0.01% of the portfolio, ranked #5578.
Citigroup first reported a position in VTAK in Q1 2022 and has held it in 3 quarters since. The position peaked at $21K in Q1 2022. 10 funds tracked by Wall St. Rank hold VTAK as of Q2 2026.
- Citigroup held 22 shares of Catheter Precision worth $19 as of Q2 2026.
- Citigroup bought 21 Catheter Precision shares in Q2 2026, an estimated $20.
- Catheter Precision made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5578 holding.
- Citigroup first reported a position in Catheter Precision in Q1 2022 and has held it in 3 quarters since.
- Citigroup's Catheter Precision position peaked at $21K in Q1 2022.
- 10 funds tracked by Wall St. Rank held Catheter Precision as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.